ALPHAPORT.AI
🇺🇸Butterfly Network, Inc.BFLY
USDUSD
SectorHealth CareIndustryMedtech
Management
Joseph M. DeVivo
CEO

Company information

Ticker
BFLY
Country
United States
Sector
Health Care
Industry
Medtech

Butterfly Network Business Summary

Butterfly Network, Inc. (BFLY) operates as a digital health innovator specializing in semiconductor-based medical imaging, utilizing a "razor-and-blade" revenue model that combines hardware sales with recurring software-as-a-service (SaaS) fees. Income is primarily derived from its proprietary Butterfly iQ3 handheld devices and tiered subscriptions for the Butterfly Cloud and Compass AI enterprise platforms, supplemented by a strategic 2026 pivot toward Ultrasound-on-Chip™ semiconductor licensing and co-development agreements. The company’s business is segmented into Clinical Point-of-Care, Veterinary, and Enterprise Solutions, with a growing emphasis on third-party API integrations through its Butterfly Garden ecosystem. Butterfly competes directly with legacy medical giants GE HealthCare (Vscan) and Philips (Lumify), as well as agile competitors such as Clarius Mobile Health and Exo. While incumbents rely on traditional piezoelectric technology, Butterfly’s silicon-based approach positions it as the high-density, low-cost disruptor aimed at making medical imaging as ubiquitous as the stethoscope. Founded in 2011 by Dr. Jonathan Rothberg—a National Medal of Technology recipient and pioneer in high-speed DNA sequencing—Butterfly is currently led by President, CEO, and Chairman Joseph M. DeVivo, who joined in 2023 with a 35-year pedigree in MedTech leadership at Teladoc Health and Smith & Nephew. The executive team is further bolstered by Executive Vice President and CFO John Doherty, formerly of Magic Leap and Verizon, and Senior Vice President and CTO Victor Ku, who was appointed in late 2025 to oversee the company’s global technology strategy and AI-driven product roadmap. Notable institutional backing includes the Bill & Melinda Gates Foundation, which supports the company’s global health initiatives, alongside significant investment from ARK Investment Management and Baillie Gifford. This leadership group combines deep semiconductor expertise with clinical scaling experience to drive Butterfly’s 2026 "inflection year" of AI integration and market expansion.

Updated 2026-07-31 · US SEC company filings
Financial Metric TrendsQuarterly⌄
Business Overview is available publicly. Financials, KPIs, reports, transcripts and the rest of Research require the Research tier.